CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, ... CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.12 | 0.604229607251 | 19.86 | 20.549 | 19 | 673343 | 19.86547973 | DR |
| 4 | 3.228 | 19.2693409742 | 16.752 | 20.549 | 16.01 | 540980 | 18.3027776 | DR |
| 12 | -3.57 | -15.1592356688 | 23.55 | 25.84 | 16.01 | 513694 | 20.13061414 | DR |
| 26 | -37.86 | -65.4564315353 | 57.84 | 67.0632 | 16.01 | 401064 | 26.45755267 | DR |
| 52 | -60.97 | -75.3180975911 | 80.95 | 89.71 | 16.01 | 264668 | 36.41091842 | DR |
| 156 | -73.37 | -78.5966791644 | 93.35 | 109 | 16.01 | 138542 | 54.45560206 | DR |
| 260 | -92.43 | -82.2257806245 | 112.41 | 117.24 | 16.01 | 105118 | 63.59539349 | DR |
Bngo
11分前
VVVVVV
14分前
Ranb2khz
37分前
FlashySage44
41分前
P-Rawl
41分前
xoom
42分前
Ranb2khz
53分前
eagle8
54分前
eagle8
1時間前
Investor082
2時間前
eagle8
2時間前
Latenightmike57
2時間前
Investor082
2時間前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。